Premium
P2‐317: Rivastigmine decreases amyloid‐β precursor protein and increases synaptic markers in primary neuronal cultures
Author(s) -
Bailey Jason A.,
Lahiri Debomoy K.
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.1394
Subject(s) - acetylcholinesterase , donepezil , rivastigmine , butyrylcholinesterase , cholinergic , cholinesterase , acetylcholine , synaptophysin , cholinergic neuron , amyloid precursor protein , chemistry , neurotoxicity , hyperphosphorylation , tau protein , pharmacology , medicine , neuroscience , alzheimer's disease , biology , aché , biochemistry , toxicity , dementia , enzyme , disease , immunohistochemistry , kinase